|
Roche biotech drug offers new way to fight asthma
Reuters The encouraging response seen with quilizumab, which the Swiss group is developing as a treatment for moderate-to-severe asthma, underscores the growing focus on novel biotech medicines for hard-to-treat cases of the disease. Other companies working … |
View full post on asthma – Google News